文献速递血管炎

巨细胞动脉炎的性别差异:西班牙ARTESER登记研究

Sex differences among patients with giant cell arteritis: insights from the Spanish ARTESER Registry.
PubMed 文献 · Rheumatology (Oxford) · 2026-01-01

该研究基于西班牙26家医院ARTESER登记中2013年6月至2019年3月诊断的1675例巨细胞动脉炎(GCA)患者,比较男女在临床表现、血管表型、诊疗、不良事件和结局方面的差异。结果显示女性更多见颅外表型、更常用csDMARDs且骨折更多,男性更多见混合表型、白内障更多且死亡率更高,而缓解率与复发率无性别差异。

要点

  • 女性GCA患者颅外表型更常见,接受csDMARDs更多,骨折发生率更高。
  • 男性GCA患者混合表型更常见,颞动脉超声阳性率更高,白内障更多且死亡率更高。
  • 男女在糖皮质激素及托珠单抗使用、缓解率和复发率上无明显差异。

核心结论

  • 女性更多表现为颅外表型、更常使用csDMARDs且骨折更多;男性更多为混合表型、白内障更多且死亡率更高。

研究设计与样本

  • 多中心登记研究,纳入西班牙26家医院2013年6月1日至2019年3月29日诊断为GCA、年龄≥50岁且经影像学、1990年ACR分类标准或专家临床判断确诊的患者,共1675例。

主要发现

  • 颅外表型女性14.8% vs 男性9.9%(P=0.039),混合表型男性17.7% vs 女性11.7%(P=0.002)。
  • 颞动脉超声阳性男性73.5% vs 女性65.1%(P=0.025)。
  • csDMARDs使用女性35.3% vs 男性28.2%(P=0.005);糖皮质激素与托珠单抗使用无性别差异。
  • 骨折女性22.4% vs 男性10.9%(P=0.010),白内障男性6.0% vs 女性2.8%(P=0.010)。
  • 缓解率23.1% vs 23.8%、复发率19.7% vs 19.3%两性相似;死亡率男性13.8% vs 女性6.6%(P<0.001)。

关键数值与推荐

  • GCA诊断依据为影像学、1990年美国风湿病学会分类标准或专家临床判断,入组年龄≥50岁。
  • 比较指标包括颅外表型(女性14.8% vs 9.9%)、混合表型(男性17.7% vs 11.7%)、csDMARDs使用(女性35.3% vs 28.2%)、骨折(女性22.4% vs 10.9%)与死亡率(男性13.8% vs 6.6%)。

临床怎么用

  • 在GCA管理中应将性别作为关键生物学变量,关注女性骨折风险与男性死亡风险,并据此制定更个体化的治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate sex-based differences in clinical presentation, vascular phenotype, diagnostic approaches, treatment, adverse events and outcomes among patients with giant cell arteritis (GCA). METHODS: We analysed data from all patients diagnosed with GCA between 1 June 2013 and 29 March 2019 across 26 hospitals in Spain. Eligibility criteria included age ≥50 years and diagnosis confirmed by imaging, the 1990 American College of Rheumatology classification criteria, or expert clinical judgment. RESULTS: A total of 1675 patients were included. The extracranial phenotype was more prevalent in women (14.8% vs 9.9%; P = 0.039), while the mixed phenotype was more common in men (17.7% vs 11.7%; P = 0.002). Temporal artery ultrasound was more frequently positive in men (73.5% vs 65.1%; P = 0.025). Conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) were prescribed more often in women (35.3% vs 28.2%; P = 0.005), while glucocorticoid and tocilizumab use did not differ by sex. Fractures (22.4% vs 10.9%; P = 0.010) and cataracts (6.0% vs 2.8%; P = 0.010) were significantly more frequent in women and men, respectively. Remission rates (23.1% vs 23.8%) and relapse frequencies (19.7% vs 19.3%) were similar between sexes. Mortality was higher in men (13.8% vs 6.6%; P < 0.001). CONCLUSIONS: Women more frequently exhibited the extracranial phenotype, required more csDMARDs, and experienced a higher incidence of fractures. In contrast, men more commonly presented with the mixed phenotype, had more cataracts, and showed a higher mortality rate. These findings highlight the importance of integrating sex as a key biological variable in GCA research and clinical management to support more tailored and effective therapeutic strategies.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Fernández-Lozano D, Domínguez-Álvaro M, Narváez J, et al. Sex differences among patients with giant cell arteritis: insights from the Spanish ARTESER Registry. Rheumatology (Oxford). 2026. PMID: 41452742. doi:10.1093/rheumatology/keaf689

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。